Literature DB >> 11955647

Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.

Geoffrey D Young1, Thomas S Winokur, Robert J Cerfolio, Brian A Van Tine, Louise T Chow, Victor Okoh, Robert I Garver.   

Abstract

Adenocarcinoma (AC), squamous cell carcinoma (SCC) and adenosquamous carcinoma (ASC) of the lung are morphologically distinguished in part by cyto-architectural features. However, little is known about the relative expression and distribution of cyto-architectural proteins among AC, SCC and ASC. Initial microarray analysis revealed significant differences in expression of two cyto-architectural genes in AC, SCC and ASC. Desmoplakin (DP) 1 and 2, which link desmosomes to intermediate filaments, was strongly expressed in SCC relative to AC and ASC. Cytokeratin 18 (CK18), an intermediate filament that is commonly linked to desmoplakin, was strongly expressed in AC and ASC relative to SCC. Western blot analysis demonstrated that AC and ASC had abundant CK18 protein, whereas CK18 was weakly detected in SCC. DP 1 and 2 are strongly expressed in SCC and minimally expressed in AC and ASC. However, the ratio of one to the other is the same in SCC and AC, but DP2 is lost in ASC. Microscopic analysis with fluorescence-labeled antibodies for CK18 and DP 1 and 2 revealed abundant membrane localization of DP and minimal perinuclear localization of CK18 in SCC. In contrast, in both AC and ASC, the CK18 protein was diffusely distributed within the cytoplasm, and DP showed both membranous and cytoplasmic localization. In conclusion, the data here shows that AC, SCC and ASC each have specific patterns of DP 1 and 2 and CK18 gene expression, protein content and biodistribution.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11955647     DOI: 10.1016/s0169-5002(01)00486-x

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

1.  A novel assay for the quantification of invasion from raft cultures of lung carcinomas.

Authors:  Victor Okoh; Geoffrey D Young; Thomas S Winokur; Robert I Garver
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.

Authors:  Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Xiaomin Luo; Wenling Zhang; Xiaoling Li; Songqing Fan; Li Cao; Ke Tang; Minghua Wu; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

3.  A novel method for sample preparation of fresh lung cancer tissue for proteomics analysis by tumor cell enrichment and removal of blood contaminants.

Authors:  Luigi De Petris; Maria Pernemalm; Göran Elmberger; Per Bergman; Lotta Orre; Rolf Lewensohn; Janne Lehtiö
Journal:  Proteome Sci       Date:  2010-02-26       Impact factor: 2.480

Review 4.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

5.  Content-based microarray search using differential expression profiles.

Authors:  Jesse M Engreitz; Alexander A Morgan; Joel T Dudley; Rong Chen; Rahul Thathoo; Russ B Altman; Atul J Butte
Journal:  BMC Bioinformatics       Date:  2010-12-21       Impact factor: 3.169

6.  FM-test: a fuzzy-set-theory-based approach to differential gene expression data analysis.

Authors:  Lily R Liang; Shiyong Lu; Xuena Wang; Yi Lu; Vinay Mandal; Dorrelyn Patacsil; Deepak Kumar
Journal:  BMC Bioinformatics       Date:  2006-12-12       Impact factor: 3.169

7.  Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.

Authors:  Anne Menz; Timo Weitbrecht; Natalia Gorbokon; Franziska Büscheck; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Sarah Minner; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Ronald Simon
Journal:  Mol Med       Date:  2021-02-15       Impact factor: 6.354

8.  Identification of logic relationships between genes and subtypes of non-small cell lung cancer.

Authors:  Yansen Su; Linqiang Pan
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

Review 9.  Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets.

Authors:  Quincy A Quick
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.